Stephen K. Burley
 |
Stephen Burley | |
|---|---|
| Born | 1958 (age 66–67) |
| Education | University of Western Ontario (BS) Exeter College, Oxford (MS, PhD) Harvard University (MD) |
| Scientific career | |
| Institutions | Rutgers University Lilly Research Laboratories Rockefeller University Howard Hughes Medical Institute |
| Thesis | Molecular arrangement in viruses studied by X-ray and neutron scattering and other physical techniques (1983) |
| Doctoral advisor | Andrew Miller |
Stephen Kevin Burley is a British-born scientist, naturalized in both Canada and the United States. He is known as an expert in structural biology, proteomics, structure/fragment based drug discovery, and clinical medicine/oncology.
He joined Rutgers, The State University of New Jersey in 2013, where he is a University Professor and Henry Rutgers Chair. Burley directs the RCSB Protein Data Bank (a member of the Worldwide Protein Data Bank), the Institute for Quantitative Biomedicine, and the Rutgers Artificial Intelligence and Data Science (RAD) Collaboratory.
Career
[edit]Burley has a Bachelor in physics from the University of Western Ontario[1] and a D.Phil from Oxford University, England in Molecular Biophysics as a Rhodes scholar.[2] Burley has an M.D. from Harvard Medical School.
He worked with Gregory A. Petsko and William N. Lipscomb at MIT and Harvard. He was faculty at Howard Hughes Medical Institute and Rockefeller University. Burley co-founded Prospect Genomics, Inc,[3] a computational genomics pharma. He was Chief Scientific Officer of SGX Pharmaceuticals after it acquired Prospect. SGX was in turn merged with Eli Lilly in 2008 where Burley was a Distinguished Lilly Research Scholar in Lilly Research Laboratories[4]
In 2012 Burley joined Rutgers [5] as Director of the Center for Integrative Proteomics Research and became director of the RCSB PDB (US regional data center for the worldwide PDB) in 2014, succeeding Prof. Helen Berman[6]
He is a member of the Editorial Board for Oncogene.[7]
Honors and awards
[edit]- Fellow of the Royal Society of Canada (elected 1995)
References
[edit]- ^ "Structural GenomiX Appoints Stephen K. Burley as Chief Scientific Officer -- re> SAN DIEGO, Oct. 16 /PRNewswire/ --". Archived from the original on 2014-10-13.
- ^ "Introducing Professor Stephen K. Burley | Department of Chemistry & Chemical Biology". Archived from the original on 2014-10-14. Retrieved 2014-10-08.
- ^ "Stocks". 30 August 2023.[dead link]
- ^ "Stephen K. Burley, M.D., D.Phil. | Center for Integrative Proteomics Research". proteomics.rutgers.edu. Archived from the original on 2016-03-10. Retrieved 2025-02-26.
- ^ "Rutgers recruits top researcher to head Center for Integrative Proteomics Research - NJBIZ". 17 December 2012.
- ^ "RCSB PDB - News". www.rcsb.org. Archived from the original on 2014-09-03.
- ^ "Editorial Board | Oncogene".